Display options
Cite
Zhang J, Xin Z. Metoprolol combined with nicorandil on unstable angina pectoris can reduce incidence of cardiovascular events and inflammatory reactions. Am J Transl Res. 2021;13(7):7906-7913
Zhang, J., & Xin, Z. (2021). Metoprolol combined with nicorandil on unstable angina pectoris can reduce incidence of cardiovascular events and inflammatory reactions. American journal of translational research, 13(7), 7906-7913.
Zhang, Junhua, and Xin, Zhi. "Metoprolol combined with nicorandil on unstable angina pectoris can reduce incidence of cardiovascular events and inflammatory reactions." American journal of translational research vol. 13,7 (2021): 7906-7913.
Zhang J, Xin Z. Metoprolol combined with nicorandil on unstable angina pectoris can reduce incidence of cardiovascular events and inflammatory reactions. Am J Transl Res. 2021 Jul 15;13(7):7906-7913. eCollection 2021. PMID: 34377269; PMCID: PMC8340211.
Copy Download .nbib Format: NLM
Share it on

Am J Transl Res. 2021 Jul 15;13(7):7906-7913. eCollection 2021.

Metoprolol combined with nicorandil on unstable angina pectoris can reduce incidence of cardiovascular events and inflammatory reactions.

American journal of translational research

Junhua Zhang, Zhi Xin

Affiliations

  1. Second Department of Cardiology, Laixi City People's Hospital Laixi 266600, Qingdao, Shandong Province, China.

PMID: 34377269 PMCID: PMC8340211

Abstract

OBJECTIVE: This research was designed to investigate the efficacy of metoprolol combined with nicorandil on unstable angina pectoris (UAP).

METHODS: Totally 174 UAP patients treated in the Laixi City People's Hospital from May 2017 to December 2019 were taken as the research objects. They were divided into the control (n=79, CG) and joint (n=95) groups (JG). Patients in the CG were treated with metoprolol, while those in the JG were treated with nicorandil. The clinical efficacy, adverse events and inflammatory reactions were observed.

RESULTS: The effective rate of the JG was better than that of the CG after treatment. There were no additional adverse reactions, and the incidence of cardiovascular events reduced. The changes of cardiac function manifested that the left ventricular end systolic diameter (LVESD) and left ventricular end diastolic diameter (LVEDD) in the JG were lower than those in the CG, while the left ventricular ejection fraction (LVEF) was higher. In addition, the serum levels of total cholesterol (TC), triglyceride (TG), high-sensitivity C-reactive protein (hs-CRP) and interleukin-6 (IL-6) in the JG were lower than those in the CG.

CONCLUSION: Metoprolol combined with nicorandil is effective for UAP patients, which reduces the incidence of cardiovascular adverse events and inhibits inflammatory reactions.

AJTR Copyright © 2021.

Keywords: Unstable angina pectoris; metoprolol; nicorandil

Conflict of interest statement

None.

References

  1. Atherosclerosis. 2011 Feb;214(2):415-21 - PubMed
  2. J Am Coll Cardiol. 2014 Jun 10;63(22):2356-62 - PubMed
  3. Circulation. 1999 Apr 27;99(16):2079-84 - PubMed
  4. Anatol J Cardiol. 2015 Feb;15(2):125-31 - PubMed
  5. Eur Cardiol. 2018 Aug;13(1):23-28 - PubMed
  6. Pharmacology. 2013;92(5-6):245-56 - PubMed
  7. Emerg Med Int. 2020 Jan 3;2020:7651610 - PubMed
  8. Biomolecules. 2021 Feb 28;11(3): - PubMed
  9. Ann Noninvasive Electrocardiol. 2020 Jul;25(4):e12736 - PubMed
  10. Eur Heart J. 1999 Jan;20(1):51-7 - PubMed
  11. J Am Coll Cardiol. 1996 Feb;27(2):311-6 - PubMed
  12. Int J Cardiol. 2011 Jan 7;146(1):4-12 - PubMed
  13. Cardiovasc Drugs Ther. 2016 Aug;30(4):367-378 - PubMed
  14. Wiad Lek. 2020;73(3):569-573 - PubMed
  15. Medicine (Baltimore). 2020 May;99(20):e20025 - PubMed
  16. J Am Coll Cardiol. 2012 Aug 14;60(7):645-81 - PubMed
  17. Biosci Rep. 2020 Jan 31;40(1): - PubMed
  18. Am J Med Sci. 2020 Sep;360(3):268-278 - PubMed
  19. Int J Cardiol. 2011 Mar 17;147(3):428-32 - PubMed
  20. Electron Physician. 2017 Aug 25;9(8):4934-4941 - PubMed
  21. Ther Adv Chronic Dis. 2020 May 18;11:2040622320922020 - PubMed
  22. Med Princ Pract. 2016;25(4):316-22 - PubMed
  23. Basic Res Cardiol. 2020 Aug 3;115(5):55 - PubMed
  24. Front Pharmacol. 2020 Mar 10;11:213 - PubMed
  25. Zhongguo Zhong Yao Za Zhi. 2021 Feb;46(3):703-711 - PubMed
  26. Exp Ther Med. 2021 Jan;21(1):26 - PubMed
  27. Medicine (Baltimore). 2020 Aug 14;99(33):e21593 - PubMed

Publication Types